339 related articles for article (PubMed ID: 23940245)
21. Risk of Acute Kidney Injury Following Contrast-enhanced CT in Hospitalized Pediatric Patients: A Propensity Score Analysis.
Gilligan LA; Davenport MS; Trout AT; Su W; Zhang B; Goldstein SL; Dillman JR
Radiology; 2020 Mar; 294(3):548-556. PubMed ID: 31961262
[TBL] [Abstract][Full Text] [Related]
22. Drug-induced acute kidney injury in neonates.
Hanna MH; Askenazi DJ; Selewski DT
Curr Opin Pediatr; 2016 Apr; 28(2):180-7. PubMed ID: 26735892
[TBL] [Abstract][Full Text] [Related]
23. Nephrotoxins and nephrotoxic acute kidney injury.
Uber AM; Sutherland SM
Pediatr Nephrol; 2020 Oct; 35(10):1825-1833. PubMed ID: 31646405
[TBL] [Abstract][Full Text] [Related]
24. Integration of urinary neutrophil gelatinase-associated lipocalin with serum creatinine delineates acute kidney injury phenotypes in critically ill children.
Stanski N; Menon S; Goldstein SL; Basu RK
J Crit Care; 2019 Oct; 53():1-7. PubMed ID: 31174170
[TBL] [Abstract][Full Text] [Related]
25. Development and performance of electronic acute kidney injury triggers to identify pediatric patients at risk for nephrotoxic medication-associated harm.
Kirkendall ES; Spires WL; Mottes TA; Schaffzin JK; Barclay C; Goldstein SL
Appl Clin Inform; 2014; 5(2):313-33. PubMed ID: 25024752
[TBL] [Abstract][Full Text] [Related]
26. Frequency of Exposure of Nephrotoxic Drugs and Drug-Induced Acute Kidney Injury in Pediatric Intensive Care Unit: A Retrospective Review From a Tertiary Care Centre in Pakistan.
Ahmed R; Shahzad M; Umer A; Azim A; Jamil MT; Haque A
Cureus; 2020 Dec; 12(12):e12183. PubMed ID: 33489594
[TBL] [Abstract][Full Text] [Related]
27. Long-Term Healthcare Cost Savings of a Pediatric Nephrotoxic Medication-Associated Acute Kidney Injury Reduction Program in a Simulated Sample.
Dynan L; Lazear D; Goldstein SL
J Pharm Pract; 2023 Aug; 36(4):795-802. PubMed ID: 35343287
[No Abstract] [Full Text] [Related]
28. Acute kidney injury during vancomycin therapy in critically ill children.
Totapally BR; Machado J; Lee H; Paredes A; Raszynski A
Pharmacotherapy; 2013 Jun; 33(6):598-602. PubMed ID: 23526674
[TBL] [Abstract][Full Text] [Related]
29. Ascertainment and epidemiology of acute kidney injury varies with definition interpretation.
Zappitelli M; Parikh CR; Akcan-Arikan A; Washburn KK; Moffett BS; Goldstein SL
Clin J Am Soc Nephrol; 2008 Jul; 3(4):948-54. PubMed ID: 18417742
[TBL] [Abstract][Full Text] [Related]
30. Nephrotoxic Medications and Risk Factors of Acute Kidney Injury in Medical Wards: A Single-Center Study.
Chuah SM; Lim AB; Ooi JQ; Osman NA; Ho PY; Loh JS; Ibrahim FH; Omar ED; Mazlan-Kepli W
Saudi J Kidney Dis Transpl; 2021; 32(4):1118-1127. PubMed ID: 35229811
[TBL] [Abstract][Full Text] [Related]
31. Serum cystatin C for acute kidney injury evaluation in children treated with aminoglycosides.
Lau L; Al-Ismaili Z; Harel-Sterling M; Pizzi M; Caldwell JS; Piccioni M; Lands LC; Mottes T; Devarajan P; Goldstein SL; Bennett MR; Zappitelli M
Pediatr Nephrol; 2017 Jan; 32(1):163-171. PubMed ID: 27743042
[TBL] [Abstract][Full Text] [Related]
32. Acute kidney injury in pediatric patients.
Kwiatkowski DM; Sutherland SM
Best Pract Res Clin Anaesthesiol; 2017 Sep; 31(3):427-439. PubMed ID: 29248148
[TBL] [Abstract][Full Text] [Related]
33. Prescriber adherence to pharmacokinetic monitoring service recommendations for aminoglycoside dosing and the risk of acute kidney injury.
Hennessy S; Leonard CE; Localio AR; Cohen A; Yang W; Cheung L; Strom BL; Herlim M; Feldman HI
Int J Clin Pharmacol Ther; 2011 Sep; 49(9):536-44. PubMed ID: 21888866
[TBL] [Abstract][Full Text] [Related]
34. Assessment of Worldwide Acute Kidney Injury, Renal Angina and Epidemiology in critically ill children (AWARE): study protocol for a prospective observational study.
Basu RK; Kaddourah A; Terrell T; Mottes T; Arnold P; Jacobs J; Andringa J; Goldstein SL;
BMC Nephrol; 2015 Feb; 16():24. PubMed ID: 25882434
[TBL] [Abstract][Full Text] [Related]
35. Effects of inpatient creatinine testing frequency on acute kidney injury identification and staging: a historical cohort study.
Oliveira CL; Duarte-Ramos F; Alves da Costa F; Fernandez-Llimos F
Int J Clin Pharm; 2024 Jun; 46(3):623-630. PubMed ID: 38315304
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for development of acute kidney injury and acute kidney disease in critically ill children.
Hui WF; Chan VPY; Cheung WL; Ku SW; Hon KL
J Nephrol; 2023 Jun; 36(5):1425-1434. PubMed ID: 37060439
[TBL] [Abstract][Full Text] [Related]
37. Evidence-based development of a nephrotoxic medication list to screen for acute kidney injury risk in hospitalized children.
Goswami E; Ogden RK; Bennett WE; Goldstein SL; Hackbarth R; Somers MJG; Yonekawa K; Misurac J
Am J Health Syst Pharm; 2019 Oct; 76(22):1869-1874. PubMed ID: 31665764
[TBL] [Abstract][Full Text] [Related]
38. Challenges in Pharmacovigilance: Variability in the Criteria for Determining Drug-Associated Acute Kidney Injury in Retrospective, Observational Studies.
Amatullah N; Stottlemyer BA; Zerfas I; Stevens C; Ozrazgat-Baslanti T; Bihorac A; Kane-Gill SL
Nephron; 2023; 147(12):725-732. PubMed ID: 37607496
[TBL] [Abstract][Full Text] [Related]
39. Acute kidney injury in children hospitalized with a relapse of nephrotic syndrome: A short-term outcome study.
Kumar R; Agrwal S; Mantan M; Yadav S
Saudi J Kidney Dis Transpl; 2021; 32(2):437-444. PubMed ID: 35017338
[TBL] [Abstract][Full Text] [Related]
40. Vancomycin-associated acute kidney injury in pediatric cardiac intensive care patients.
Moffett BS; Hilvers PS; Dinh K; Arikan AA; Checchia P; Bronicki R
Congenit Heart Dis; 2015; 10(1):E6-10. PubMed ID: 24934335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
